Early research (Phase 1)Study completedNCT03679754
What this trial is testing
Evaluation of Ad-RTS-hIL-12 + Veledimex in Subjects With Recurrent or Progressive Glioblastoma, a Substudy to ATI001-102
Who this might be right for
Glioblastoma
Alaunos Therapeutics 36